Follow
a.paradiso@oncologico.bari.it
a.paradiso@oncologico.bari.it
istituto tumori bari
Verified email at oncologico.bari.it
Title
Cited by
Cited by
Year
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
97012013
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
61412005
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer
JA Foekens, D Atkins, Y Zhang, FC Sweep, N Harbeck, A Paradiso, ...
J Clin Oncol 24 (11), 1665-1671, 2006
4372006
The complexity of targeting EGFR signalling in cancer: from expression to turnover
S Sebastian, J Settleman, SJ Reshkin, A Azzariti, A Bellizzi, A Paradiso
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1766 (1), 120-139, 2006
3942006
The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin—one single nature
S Harguindey, G Orive, JL Pedraz, A Paradiso, SJ Reshkin
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1756 (1), 1-24, 2005
3352005
NHE1 promotes invadopodial ECM proteolysis through acidification of the peri‐invadopodial space
G Busco, RA Cardone, MR Greco, A Bellizzi, M Colella, E Antelmi, ...
The FASEB Journal 24 (10), 3903-3915, 2010
2572010
Corrigendum: Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, S Aparicio, S Behjati, ...
Nature 502 (7470), 258-258, 2013
2292013
Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
A Paradiso, G Simone, S Petroni, B Leone, C Vallejo, J Lacava, A Romero, ...
British journal of cancer 82 (3), 560-567, 2000
2202000
Australian Pancreatic Cancer Genome I
LB Alexandrov, S Nik-Zainal, DC Wedge, SA Aparicio, S Behjati, ...
Consortium IBC, Consortium IM-S, PedBrain I, Zucman-Rossi J, Futreal PA …, 2013
2172013
Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of β‐tubulins
S Tommasi, A Mangia, R Lacalamita, A Bellizzi, V Fedele, A Chiriatti, ...
International journal of cancer 120 (10), 2078-2085, 2007
2132007
Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer
A Paradiso, A Mangia, A Chiriatti, S Tommasi, A Zito, A Latorre, F Schittulli, ...
Annals of Oncology 16, iv14-iv19, 2005
1962005
Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na+/H+ exchange, motility, and invasion induced by serum deprivation
SJ Reshkin, A Bellizzi, V Albarani, L Guerra, M Tommasino, A Paradiso, ...
Journal of Biological Chemistry 275 (8), 5361-5369, 2000
1762000
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
Y Zhang, AM Sieuwerts, M McGreevy, G Casey, T Cufer, A Paradiso, ...
Breast cancer research and treatment 116, 303-309, 2009
1702009
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors
P Parrella, ML Poeta, AP Gallo, M Prencipe, M Scintu, A Apicella, ...
Clinical Cancer Research 10 (16), 5349-5354, 2004
1702004
Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer
R Divella, A Mazzocca, A Daniele, C Sabbà, A Paradiso
International journal of biological sciences 15 (3), 610, 2019
1612019
The NHERF1 PDZ2 domain regulates PKA–RhoA–p38-mediated NHE1 activation and invasion in breast tumor cells
RA Cardone, A Bellizzi, G Busco, EJ Weinman, ME Dell'Aquila, ...
Molecular biology of the cell 18 (5), 1768-1780, 2007
1482007
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies
G Ranieri, CD Gadaleta, R Patruno, N Zizzo, MG Daidone, MG Hansson, ...
Critical reviews in oncology/hematology 88 (1), 187-197, 2013
1382013
Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines
RA Cardone, A Bagorda, A Bellizzi, G Busco, L Guerra, A Paradiso, ...
Molecular biology of the cell 16 (7), 3117-3127, 2005
1342005
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients …
S Maier, I Nimmrich, T Koenig, S Eppenberger-Castori, I Bohlmann, ...
European Journal of Cancer 43 (11), 1679-1686, 2007
1302007
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines …
A Azzariti, NA Colabufo, F Berardi, L Porcelli, M Niso, GM Simone, ...
Molecular cancer therapeutics 5 (7), 1807-1816, 2006
1302006
The system can't perform the operation now. Try again later.
Articles 1–20